aTyr Pharma, Inc. (LIFE)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about aTyr Pharma, Inc. (LIFE)
Go deeper and ask any question about LIFE
Company Performance
Current Price
as of Sep 13, 2024$1.90
P/E Ratio
N/A
Market Cap
$144.01M
Description
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Metrics
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerLIFE
- Price$1.9+1.60%
Trading Information
- Market Cap$144.01M
- Float97.39%
- Average Daily Volume (1m)288,664
- Average Daily Volume (3m)380,554
- EPS-$0.91
Company
- Revenue$0.59M
- Rev Growth (1yr)N/A
- Net Income-$16.31M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$16.93M
- EV$47.95M
- EV/Revenue81.55
- P/EN/A
- P/S233.57
Documents
SEC Filings
Factset Street Account
Factset